Heavy Ion & Proton Therapy - Precision Particle Beam Radiotherapy

Advanced particle beam therapy for nasopharyngeal cancer, lung cancer, prostate cancer, and other solid tumors. 5-year survival rate 70.4% with minimal damage to surrounding tissues.

Precision radiotherapy using proton and carbon ion beams for targeted tumor destruction.

  • Nasopharyngeal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Pediatric Tumors
  • Bragg peak precision targeting
  • Minimal exit dose to healthy tissue
  • 5-year survival rate 70.4%
  • Suitable for radioresistant tumors
  • Lower long-term side effects